PHARMACCESS LIMITED

Company number 06942754 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£300k -£200k -£100k £0 £100k £200k £300k £400k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £95,266 Total assets 2017: £114,638 Total assets 2018: £189,730 Total assets 2019: £247,162 Total assets 2020: £318,488 Total assets 2021: £257,214 Total assets 2022: £119,579 Total assets 2023: £81,997 Total assets 2024: £61,397 Total assets 2025: £49,229 Total assets Net assets 2019: £58,393 Net assets 2020: £77,461 Net assets 2021: £27,663 Net assets 2022: -£40,473 Net assets 2024: -£93,831 Net assets 2025: -£102,118 Net assets Total liabilities 2016: -£200,000 Total liabilities 2017: -£200,000 Total liabilities 2018: -£205,057 Total liabilities 2019: -£220,026 Total liabilities 2020: -£224,333 Total liabilities 2021: -£207,851 Total liabilities 2022: -£158,840 Total liabilities 2023: -£155,344 Total liabilities 2024: -£155,228 Total liabilities 2025: -£151,347 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 1 1 2 2 3 2024 2025 2024: 3 2025: 3

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 13 years

Latest accounts (2025-12-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-12-31 £49,229 -£151,347 -£102,118 3
2024-12-31 £61,397 -£155,228 -£93,831 3
2023-12-31 £81,997 -£155,344
2022-12-31 £119,579 -£158,840 -£40,473
2021-12-31 £257,214 -£207,851 £27,663
2020-12-31 £318,488 -£224,333 £77,461
2019-12-31 £247,162 -£220,026 £58,393
2018-12-31 £189,730 -£205,057
2017-12-31 £114,638 -£200,000
2016-12-31 £95,266 -£200,000
2015-12-31 £203,691 -£204,918 -£21,829
2014-12-31 £235,665 -£230,768 £4,897 £74,523
2013-12-31 £46,462 -£33,183 £13,279 £366

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.